We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$39.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.48B
Cap. Flow %
6.28%
Top 10 Hldgs %
5.86%
Holding
3,447
New
176
Increased
1,376
Reduced
1,602
Closed
253

Sector Composition

Rank Sector Weight
1 Financials 10.78%
2 Consumer Discretionary 10.44%
3 Technology 10.24%
4 Industrials 10.05%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZAZA
3101
DELISTED
ZAZA ENERGY CORP COM NEW
ZAZA
$39K ﹤0.01%
4,436
+251
+6% +$1.62K
GERN icon
3102
Geron
GERN
$828M
$38K ﹤0.01%
12,381
+1,369
+12% +$2.86K
VXRT
3103
DELISTED
Vaxart
VXRT
$37K ﹤0.01%
1,176
-118
-9% -$4.93K
DFBG
3104
DELISTED
Differential Brands Group Inc
DFBG
$37K ﹤0.01%
1,161
-116
-9% -$3.64K
ATNY
3105
DELISTED
API TECHNOLOGIES CORP. COMMON STOCK
ATNY
$37K ﹤0.01%
13,548
-8,075
-37% -$20.8K
SURG
3106
DELISTED
SYNERGETICS USA, INC.
SURG
$37K ﹤0.01%
11,820
-1,182
-9% -$3.9K
MDW
3107
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$37K ﹤0.01%
41,243
-49,991
-55% -$43.6K
IPAS
3108
DELISTED
Ipass Inc Common Stock
IPAS
$36K ﹤0.01%
3,011
-301
-9% -$4.24K
SEEL
3109
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
BIOL
3110
DELISTED
Biolase, Inc.
BIOL
$35K ﹤0.01%
1
-1
-50% -$25.5K
GMO
3111
DELISTED
General Moly, Inc.
GMO
$35K ﹤0.01%
30,396
-1,748
-5% -$1.82K
VRS
3112
DELISTED
VERSO CORP COM STK (DE)
VRS
$35K ﹤0.01%
16,663
-1,666
-9% -$4.12K
DVAX
3113
DELISTED
Dynavax Technologies
DVAX
$34K ﹤0.01%
2,094
-117
-5% -$1.76K
ELON
3114
DELISTED
Echelon Corp
ELON
$34K ﹤0.01%
1,380
-138
-9% -$3.55K
UPI
3115
DELISTED
UROPLASTY INC-NEW
UPI
$34K ﹤0.01%
12,571
-1,256
-9% -$3.94K
HNSN
3116
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$33K ﹤0.01%
2,553
-255
-9% -$4.43K
DNDN
3117
DELISTED
DENDREON CORPORATION
DNDN
$33K ﹤0.01%
14,137
+931
+7% +$2.18K
ZIPR
3118
DELISTED
ZIP REALTY, INC
ZIPR
$33K ﹤0.01%
10,902
-1,090
-9% -$3.52K
CVM icon
3119
CEL-SCI Corp
CVM
$20.3M
$32K ﹤0.01%
34
+2
+6% +$1.82K
FRTX
3120
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$32K ﹤0.01%
8
-6
-43% -$22.6K
ALSK
3121
DELISTED
Alaska Communications Systems
ALSK
$32K ﹤0.01%
18,024
-1,802
-9% -$3.31K
ZN
3122
DELISTED
Zion Oil & Gas, Inc.
ZN
$32K ﹤0.01%
15,399
-1,540
-9% -$3.28K
VRML
3123
DELISTED
Vermillion, Inc.
VRML
$32K ﹤0.01%
12,268
-1,226
-9% -$3.51K
LXRX icon
3124
Lexicon Pharmaceuticals
LXRX
$1.03B
$31K ﹤0.01%
2,720
-223
-8% -$2.4K
ARQL
3125
DELISTED
Arqule Inc
ARQL
$31K ﹤0.01%
19,969
-12,245
-38% -$19.2K

Similar funds

Guggenheim Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Guggenheim Capital held 3,447 positions worth $39.5B, up 12% from $35.2B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Guggenheim Capital deployed $2.48B of net new capital in Q2 2014, opening 176 new positions and adding to 1,376 existing holdings. Its largest new stake was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $95.8M trimmed.

  • Guggenheim Capital's largest Q2 2014 buy was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.
  • Guggenheim Capital added most to Stanley Black & Decker in Q2 2014, an estimated $62.1M increase.
  • Guggenheim Capital's biggest Q2 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $95.8M.
  • Guggenheim Capital fully exited LSI CORPORATION in Q2 2014, selling an estimated $44.6M.
  • Guggenheim Capital's ten largest holdings make up 5.9% of its $39.5B portfolio in Q2 2014.
  • Guggenheim Capital opened 176 new positions and closed 253 in Q2 2014.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $39.5B.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.